AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- Open
- $154.99
- 52-wk high
- $186.12
- High
- $155.81
- 52-wk low
- $122.14
- Low
- $152.50
- Prev close
- $155.54
Smart money
Earnings
Earnings came in 25.5% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $794.9M | $805.5M | $814.5M | $959.0M |
| Cost of what it sold | $14.0M | $17.6M | $13.8M | $23.2M |
| Gross profit | $780.9M | $787.9M | $800.7M | $935.8M |
| What it spent | ||||
| Research and development | $250.0M | $258.2M | $296.2M | $326.7M |
| Sales and admin | $291.6M | $301.8M | $318.5M | $439.7M |
| Other operating costs | — | $17.0M | — | $16.4M |
| Total operating expenses | $541.9M | $577.0M | $614.7M | $782.8M |
| What was left | ||||
| Operating profit | $239.0M | $210.9M | $186.0M | $153.0M |
| Interest on debt | — | — | — | $2.9M |
| Profit before tax | $291.8M | $239.4M | $246.8M | $162.2M |
| Tax | $82.3M | $85.7M | $48.9M | $17.8M |
| Net profit | $209.5M | $153.7M | $197.9M | $144.4M |
| EBITDA | $299.5M | $235.4M | $193.3M | $189.9M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
30oversold
20D volatility
48%annualized
52-week range
$122.14$186.12
20D support
News
What the news says
32 articles · 7 days
Coverage leans bullish
Tone of tracked coverage
Neurocrine Biosciences (NBIX) Could Be 28% Undervalued On Fresh INGREZZA Data
Leans bullishAug 19Neurocrine Biosciences (NBIX) Could Be 28% Undervalued On Fresh INGREZZA Data
Leans bullishAug 18NBIX Stock Dips 12% in a Month: Time to Buy, Hold or Sell?
NeutralAug 17
